Terms: = Liver cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Diagnosis
11 results:
1. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
2. Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma.
Lee HW; Kim E; Cho KJ; Park HJ; Seo J; Lee H; Baek E; Choi JR; Han KH; Lee ST; Park JY
Liver Int; 2022 Oct; 42(10):2317-2326. PubMed ID: 35776657
[TBL] [Abstract] [Full Text] [Related]
3. Identification of novel biomarkers in prostate cancer diagnosis and prognosis.
Li W; Xu W; Sun K; Wang F; Wong TW; Kong AN
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23137. PubMed ID: 35686336
[TBL] [Abstract] [Full Text] [Related]
4. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-nrf2 signaling.
Yang Y; Zheng J; Wang M; Zhang J; Tian T; Wang Z; Yuan S; Liu L; Zhu P; Gu F; Fu S; Shan Y; Pan Z; Zhou W
Cancer Sci; 2021 Feb; 112(2):641-654. PubMed ID: 33222332
[TBL] [Abstract] [Full Text] [Related]
5. A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
Cairo S; Armengol C; Maibach R; Häberle B; Becker K; Carrillo-Reixach J; Guettier C; Vokuhl C; Schmid I; Buendia MA; Branchereau S; von Schweinitz D; Kappler R
Eur J Cancer; 2020 Dec; 141():30-39. PubMed ID: 33125945
[TBL] [Abstract] [Full Text] [Related]
6. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract] [Full Text] [Related]
7. The role of nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance.
Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Samadi N
Tumour Biol; 2017 Jun; 39(6):1010428317705510. PubMed ID: 28621229
[TBL] [Abstract] [Full Text] [Related]
8. Paediatric hepatocellular carcinoma due to somatic CTNNB1 and nfe2l2 mutations in the setting of inherited bi-allelic ABCB11 mutations.
Vilarinho S; Erson-Omay EZ; Harmanci AS; Morotti R; Carrion-Grant G; Baranoski J; Knisely AS; Ekong U; Emre S; Yasuno K; Bilguvar K; Günel M
J Hepatol; 2014 Nov; 61(5):1178-83. PubMed ID: 25016225
[TBL] [Abstract] [Full Text] [Related]
9. Exploration of liver cancer genomes.
Shibata T; Aburatani H
Nat Rev Gastroenterol Hepatol; 2014 Jun; 11(6):340-9. PubMed ID: 24473361
[TBL] [Abstract] [Full Text] [Related]
10. Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results.
Ambrosino G; Polistina F; Costantin G; Francescon P; Guglielmi R; Zanco P; Casamassima F; Febbraro A; Gerunda G; Lumachi F
Anticancer Res; 2009 Aug; 29(8):3381-4. PubMed ID: 19661360
[TBL] [Abstract] [Full Text] [Related]
11. Combined hepatocholangiocarcinoma: case-series and review of literature.
Bhagat V; Javle M; Yu J; Agrawal A; Gibbs JF; Kuvshinoff B; Nava E; Iyer R
Int J Gastrointest Cancer; 2006; 37(1):27-34. PubMed ID: 17290078
[TBL] [Abstract] [Full Text] [Related]
